Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT00236067

Public ClinicalTrials.gov record NCT00236067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 8:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril(up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder

Study identification

NCT ID
NCT00236067
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
440 participants

Conditions and interventions

Interventions

  • Gabitril Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Not listed
Completion
Feb 28, 2006
Last update posted
May 8, 2014

2004 – 2006

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Birmingham Research Group Birmingham Alabama 35216
Southwestern Research Institute Beverly Hills California 90210
Pharmacology Research Institute Northridge California 91324
Pacific Clinical Research Orange California 92868
Carman Research Smyrna Georgia 30080
Hawaii Clinical Research Center Honolulu Hawaii 96826
Hartford Research Group Florence Kentucky 41042
Summit Research Network Okemos Michigan 48864
CNS Research Institute Clementon New Jersey 08021
Social Psychiatry Research Inst. Brooklyn New York 11235
Neurobehavioral Research, Inc. Lawrence New York 11559
Social Psychiatry Research Inst. New York New York 10021
The Medical Research Network New York New York 10024
Northcoast Clinical Trials Beachwood Ohio 44122
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Summit Research Network Portland Oregon 97209
University of Pennsylvania Philadelphia Pennsylvania 19104
Carolina Clinical Research Services Columbia South Carolina 29201
Radiant Research, Salt Lake City Salt Lake City Utah 84107-7591
Comprehensive Neuroscience of Northern Virginia Arlington Virginia 22201
Summit Research Network Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00236067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2014 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00236067 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →